Six cases of daptomycin-non-susceptible Staphylococcus aureus bacteraemia in Singapore

Journal of Medical Microbiology

Volumn 59, Issue 12, 2010, Pages 1509-1513

  Hsu, Li Yang ^a   Leong, Micky ^a   Balm, Michelle ^a   Chan, Douglas S ^a   Huggan, Paul ^a   Tan, Thean Yen ^b   Koh, Tse Hsien ^c   Hon, Pei Yun ^a   Ng, Mary M ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; OXACILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL CELL WALL; BACTERIUM ISOLATE; BELOW KNEE AMPUTATION; BLOOD CULTURE; CERVICAL MYELOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DISKITIS; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; FATALITY; FEMALE; FOOT ULCER; HUMAN; MALE; METASTASIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; OVARY CANCER; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; SINGAPORE; STAPHYLOCOCCAL BACTEREMIA; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGAPORE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 78649433854     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.022533-0     Document Type: Article

References (13)

1. Camargo, I. L., Neoh, H. M., Cui, L. & Hiramatsu, K. (2008). Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob Agents Chemother 52, 4289-4299.
2. Cubist Pharmaceuticals (2008). Cubicin (daptomycin) [package insert]. Cubist Pharmaceuticals, Lexington, MA, USA.
3. Cui, L., Tominaga, E., Neoh, H. M. & Hiramatsu, K. (2006). Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50, 1079-1082. (Pubitemid 43327815)
4. Enright, M. C., Day, N. P., Davies, C. E., Peacock, S. J. & Spratt, B. G. (2000). Multilocus sequence typing for characterization of methicillin-resistant and methicillin-sensitive clones of Staphylococcus aureus. J Clin Microbiol 38, 1008-1015.
5. Hsu, L. Y., Loomba-Chlebicka, N., Koh, Y. L., Tan, T. Y., Krishnan, P., Lin, R. T., Tee, N. W., Fisher, D. A. & Koh, T. H. (2007). Evolving EMRSA-15 epidemic in Singapore hospitals. J Med Microbiol 56, 376-379. (Pubitemid 46363983)
6. Ito, T., Ma, X. X., Takeuchi, F., Okuma, K., Yuzawa, H. & Hiramatsu, K. (2004). Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 48, 2637-2651. (Pubitemid 38823437)
7. Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S. J., Proctor, R. A., Sahl, H. G., Schrenzel, J., Xiong, Y. Q. & Bayer, A. S. (2008). Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 52, 269-278.
8. Lee, C. H., Wang, M. C., Huang, I. W., Chen, F. J. & Lauderdale, T. L. (2010). Development of daptomycin nonsusceptibility with heterogeneous vancomycin intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment. Antimicrob Agents Chemother 54, 4038-4040.
9. Mariani, P. G., Sader, H. S. & Jones, R. N. (2006). Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. J Antimicrob Chemother 58, 481-483.
10. Maslow, J., Slutsky, A. & Arbeit, R. (1993). The application of pulsed-field gel electrophoresis to molecular epidemiology. In Diagnostic Molecular Microbiology: Principles and Applications, pp. 563-572. Edited by H. Persing, T. Smith, F. Tenover & T. White. Washington, DC: American Society for Microbiology.
11. Moise, P. A., North, D., Steenbergen, J. N. & Sakoulas, G. (2009). Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 9, 617-624.
12. Sakoulas, G., Alder, J., Thauvin-Eliopoulos, C., Moellering, R. C., Jr & Eliopoulos, G. M. (2006). Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 50, 1581-1585.
13. Sakoulas, G., Brown, J., Lamp, K. C., Friedrich, L. V. & Lindfield, K. C. (2009). Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience. Clin Ther 31, 1936-1945.